National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 618555

History of Changes from the VAERS Wayback Machine

First Appeared on 6/14/2017

VAERS ID: 618555
VAERS Form:
Age:13.0
Gender:Female
Location:Foreign
Vaccinated:2014-08-26
Onset:2014-08-26
Submitted:2015-11-17
Entered:2015-11-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. J007883 / - UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Pain, Syncope

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions: 11/01/2013 to 11/01/2013, GARDASIL, One dose of GARDASIL batch number J007883 has been administered on 01-Nov-2013.
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1511IRL007655

Write-up: Information has been received from Sanofi Pasteur MSD (SPM) (manufacturer control # IE-1577272925-E2015-12871) on 13-NOV-2015. This case was received from the health authority on 11-Nov-2015. Ref IE-HPRA-2015-025099. This case is not medically confirmed as the reporter is a consumer. A 13 year old female patient who was not taking any concomitant medication received injections of GARDASIL, (batch number J007883), route and site not reported, between 01-Nov-2013 and 26-Aug-2014. On 26-Aug-2014, post vaccination, the patient experienced chronic pain and fainting. Corrective treatment included pain killers and anti-inflammatories. At the time of reporting the patient''s symptoms were persisting. The reporter considered the events to be serious due to hospitalisation and disability.


Changed on 9/14/2017

VAERS ID: 618555 Before After
VAERS Form:(blank) 1
Age:13.0
Gender:Female
Location:Foreign
Vaccinated:2014-08-26
Onset:2014-08-26
Submitted:2015-11-17
Entered:2015-11-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. J007883 / - UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Pain, Syncope

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions: 11/01/2013 to 11/01/2013, GARDASIL, One dose of GARDASIL batch number J007883 has been administered on 01-Nov-2013.
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1511IRL007655

Write-up: Information has been received from Sanofi Pasteur MSD (SPM) (manufacturer control # IE-1577272925-E2015-12871) on 13-NOV-2015. This case was received from the health authority on 11-Nov-2015. Ref IE-HPRA-2015-025099. This case is not medically confirmed as the reporter is a consumer. A 13 year old female patient who was not taking any concomitant medication received injections of GARDASIL, (batch number J007883), route and site not reported, between 01-Nov-2013 and 26-Aug-2014. On 26-Aug-2014, post vaccination, the patient experienced chronic pain and fainting. Corrective treatment included pain killers and anti-inflammatories. At the time of reporting the patient''s symptoms were persisting. The reporter considered the events to be serious due to hospitalisation and disability.


Changed on 2/14/2018

VAERS ID: 618555 Before After
VAERS Form:1
Age:13.0
Gender:Female
Location:Foreign
Vaccinated:2014-08-26
Onset:2014-08-26
Submitted:2015-11-17
Entered:2015-11-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. J007883 / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Pain, Syncope

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions: 11/01/2013 to 11/01/2013, GARDASIL, One dose of GARDASIL batch number J007883 has been administered on 01-Nov-2013.
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1511IRL007655

Write-up: Information has been received from Sanofi Pasteur MSD (SPM) (manufacturer control # IE-1577272925-E2015-12871) on 13-NOV-2015. This case was received from the health authority on 11-Nov-2015. Ref IE-HPRA-2015-025099. This case is not medically confirmed as the reporter is a consumer. A 13 year old female patient who was not taking any concomitant medication received injections of GARDASIL, (batch number J007883), route and site not reported, between 01-Nov-2013 and 26-Aug-2014. On 26-Aug-2014, post vaccination, the patient experienced chronic pain and fainting. Corrective treatment included pain killers and anti-inflammatories. At the time of reporting the patient''s symptoms were persisting. The reporter considered the events to be serious due to hospitalisation and disability.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=618555&WAYBACKHISTORY=ON


Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166